Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00187720 · ClinicalTrials.gov registry record · Phase 4
Genetic Basis for Variation in the Renal Elimination of Metformin
A Phase 4 study of Other Conditions That May Be A Focus of Clinical Attention, sponsored by University of California, San Francisco.
- Completed
- Registry status
- Phase 4
- Development phase
- 23
- Enrollment target
- 1
- Study location
NCT00187720 is a Phase 4 study of Other Conditions That May Be A Focus of Clinical Attention that has completed, run by University of California, San Francisco. The registered enrollment target is 23 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00187720, a Phase 4 study of Other Conditions That May Be A Focus of Clinical Attention, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 23 participants
- Enrollment target
- 1
- Study location
Study Summary
The current study is part of a large multi-investigator grant to look at the pharmacogenetics of a number of membrane transporters. We will study individuals with particular genotypes of the human organic cation transporter, (hOCT2), to test the hypothesis that genetic variation in hOCT2 is associated with variation in the renal clearance of the antidiabetic agent, metformin.
Conditions Studied
Interventions
- DRUG Metformin
Study Locations (1)
California
- San Francisco General Hospital - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2002-05 |
| Est. Completion | 2008-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00187720
The ClinicalTrials.gov registry entry for NCT00187720 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Other Conditions That May Be A Focus of Clinical Attention appearing as the primary indexed condition, and to 1 intervention - of which Metformin is the first listed.
NCT00187720 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT00187720 about?
NCT00187720 is a clinical study titled "Genetic Basis for Variation in the Renal Elimination of Metformin". The current study is part of a large multi-investigator grant to look at the pharmacogenetics of a number of membrane transporters. We will study individuals with particular genotypes of the human organic cation transporter, (hOCT2), to test the hypothesis that genetic variation in hOCT2 is associat...
What is the current status of trial NCT00187720?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 23 participants. The study started on 2002-05. Estimated completion is 2008-04.
What conditions does trial NCT00187720 study?
This clinical trial studies the following conditions: Other Conditions That May Be A Focus of Clinical Attention.
What interventions are being tested in trial NCT00187720?
The interventions under investigation include: Metformin (DRUG).
Who is sponsoring clinical trial NCT00187720?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00187720 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.